eWeLL Featured as Investee Company in Sumitomo Mitsui DS Asset Management's "Impact Report 2025-2026"

In the "Impact Report 2025-2026 (Japanese Equity Impact Investment Strategy)" (hereinafter referred to as "the Strategy") issued by Sumitomo Mitsui DS Asset Management, eWeLL Inc. (eWeLL, Stock Code: 5038, Headquarters: Chuo-ku, Osaka), which promotes DX for quality and productivity improvement in home healthcare, has been featured in the section introducing three investee companies of the Strategy.

In the report, eWeLL is positioned as a company related to the social issue of "demographic change."

In the context of Japan's aging population, eWeLL is recognized for its efforts to improve productivity through home healthcare DX and optimize medical resources in response to structural challenges such as labor shortages and operational inefficiencies in visiting nursing.

[Impact Report '25-26](https://www.smd-am.co.jp/corporate/responsible_investment/esg/integration/table/pdf/2025-2026_impact_report.pdf)
Source: "Impact Report 2025-2026 (Japanese Equity Impact Investment Strategy)" by Sumitomo Mitsui DS Asset Management. This release is based in part on information introduced in a third-party report and is not intended to recommend specific stocks or financial products.

## Points Evaluated (Summary)
### 1. Improvement of Visiting Nurse Productivity
The report highlights eWeLL's efforts to improve productivity through DX, such as the "iBow" dedicated electronic health record for visiting nursing, addressing challenges like labor shortages and heavy workloads in visiting nursing.

### 2. Optimization of Medical Resources
Leveraging eWeLL's accumulated data from over 9.2 million patients and 94 million visiting nursing records nationwide (as of December 2025) and its network, platforms like the "CareLogtto" community integrated care platform show potential for optimizing medical resources.